MQS Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $377K | Sell |
5,396
-352
| -6% | -$24.6K | 0.21% | 206 |
|
2025
Q1 | $422K | Buy |
+5,748
| New | +$422K | 0.24% | 171 |
|
2024
Q4 | – | Sell |
-10,681
| Closed | -$832K | – | 63 |
|
2024
Q3 | $832K | Buy |
10,681
+8,033
| +303% | +$626K | 0.46% | 34 |
|
2024
Q2 | $207K | Sell |
2,648
-5,336
| -67% | -$416K | 0.12% | 353 |
|
2024
Q1 | $541K | Buy |
+7,984
| New | +$541K | 0.31% | 105 |
|
2023
Q4 | – | Sell |
-8,489
| Closed | -$575K | – | 460 |
|
2023
Q3 | $575K | Buy |
8,489
+3,328
| +64% | +$225K | 0.35% | 72 |
|
2023
Q2 | $369K | Buy |
+5,161
| New | +$369K | 0.25% | 152 |
|
2022
Q4 | – | Sell |
-10,936
| Closed | -$600K | – | 382 |
|
2022
Q3 | $600K | Buy |
10,936
+7,693
| +237% | +$422K | 0.39% | 64 |
|
2022
Q2 | $214K | Buy |
+3,243
| New | +$214K | 0.15% | 308 |
|
2022
Q1 | – | Sell |
-5,979
| Closed | -$348K | – | 340 |
|
2021
Q4 | $348K | Buy |
+5,979
| New | +$348K | 0.56% | 64 |
|